Back to Stocks

DLHC

DLH Holdings Corp.
7 filings tracked
technologycloud computingMICRO (<$300M)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

DLH Holdings is currently navigating a deliberate strategic pivot, transitioning away from lower-margin legacy pharmacy and logistics work to focus on high-value federal priorities.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The narrative of a strategic pivot masks a stark reality: a 29% revenue collapse in the first half of fiscal 2026.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every DLHC filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The latest 10-Q reveals a company at a critical inflection point, where the success of the investment thesis depends entirely on the speed of its transition. The immediate financial impact of losing legacy VA and HHS contracts has been severe, resulting in a net loss for the quarter and a significant drop in half-year revenue. However, the company has avoided a goodwill impairment charge thus far, and its Adjusted EBITDA remains positive, suggesting that the underlying business is not yet in a death spiral. Investors must weigh the risk of a liquidity crunch against the potential for a high-margin rebirth. The massive backlog provides a cushion, but the erosion of the funded portion of that backlog is a red flag. The ultimate outcome will be determined by whether DLH can successfully replace lost commodity revenue with high-tech prime contracts before its 2027 debt obligations become insurmountable.

Selected Quarter

Core Takeaway

DLH is intentionally shedding low-margin legacy contracts to pivot toward high-tech federal services, but this is causing a temporary revenue crash and tightening liquidity.

Investor Lens

The trade-off is between the current revenue collapse and the potential for a leaner, higher-margin business model.

Watch Next

The conversion of the $75 million funded backlog into actual revenue and the impact of the 2027 debt maturity.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.53Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%
bearishMay 6

Net loss of $3.86 million for the six months ended March 31, 2026, compared to a profit in the prior year.

earnings miss
90%
bearishMay 6

G&A expenses as a percentage of revenue increased to 11.9% from 9.1% due to revenue volume decline.

margin compression
70%
neutralMay 6

Company is managing a $122M term loan with a maturity date of December 2027.

debt restructure
50%

Filing History

10-QMay 6, 2026
Expand Sequence

The latest 10-Q reveals a company at a critical inflection point, where the success of the investment thesis depends entirely on the speed of its transition. The immediate financial impact of losing legacy VA and HHS contracts has been severe, resulting in a net loss for the quarter and a significant drop in half-year revenue. However, the company has avoided a goodwill impairment charge thus far, and its Adjusted EBITDA remains positive, suggesting that the underlying business is not yet in a death spiral. Investors must weigh the risk of a liquidity crunch against the potential for a high-margin rebirth. The massive backlog provides a cushion, but the erosion of the funded portion of that backlog is a red flag. The ultimate outcome will be determined by whether DLH can successfully replace lost commodity revenue with high-tech prime contracts before its 2027 debt obligations become insurmountable.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.